MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Go back to MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Macrogenics (MGNX) Tops Q3 EPS by 69c, Beats on Revenue

November 5, 2024 4:03 PM EST

Macrogenics (NASDAQ: MGNX) reported Q3 EPS of $0.90, $0.69 better than the analyst estimate of $0.21. Revenue for the quarter came in at $110.71 million versus the consensus estimate of $87.61 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

... More